Type-2 fuzzy logic systems have recently been utilized in many control processes due to their ability to model uncertainty. This research article proposes the position control of (DC) motor. The proposed algorithm of this article lies in the application of a genetic algorithm interval type-2 fuzzy logic controller (GAIT2FLC) in the design of fuzzy controller for the position control of DC Motor. The entire system has been modeled using MATLAB R11a. The performance of the proposed GAIT2FLC is compared with that of its corresponding conventional genetic algorithm type-1 FLC in terms of several performance measures such as rise time, peak overshoot, settling time, integral absolute error (IAE) and integral of time multiplied absolute error (ITAE) and in each case, the proposed scheme shows improved performance over its conventional counterpart. Extensive simulation studies are conducted to compare the response of the given system with the conventional genetic algorithm type-1 fuzzy controller to the response given with the proposed GAIT2FLC scheme.
Uncertainty is an inherent part in controllers for real world applications. In this paper we compare the performance differences between type-1 and interval type-2 fuzzy logic (IT2FLC) controllers, with five and three term membership functions. The controllers are used to control a PM DC motor in a closed loop real time system. The performance of system with each controller to a step is recorded. The results showed that there is a statistical difference between the fuzzy logic type-1 and type-2 controllers. It is also found that a type-2 five term controller is as good as a type-1five term or type-2 three term controller
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.